MRSi 2022: 20 Years Of Innovation In Reproductive Medicine
David Stern, MBA
David Stern has over 30 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, a member of the IVIRMA global network the largest IVF network in the world. David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience. David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.
Sessions
The Impact Of Private Equity In Fertility - Sponsored By Univfy
Thursday, June 9, 2022
3:30pm - 4:15pm CST